Infrequent alterations of the RARα gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines

Blood

Volumn 87, Issue 10, 1996, Pages 4399-4403

  Morosetti, Roberta ^b   Grignani, Francesco ^b   Liberatore, Concetta ^b   Pelicci, Pier Giuseppe ^b   Schiller, Gary J ^b   Kizaki, Masahiro ^b   Bartram, Claus R ^b   Miller, Carl W ^b   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL IMMORTALIZATION; CELL LINE; GENE MUTATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LIGAND BINDING; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0029940731     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.10.4399.bloodjournal87104399     Document Type: Article

References (36)

1. Evans RM: The steroid and thyroid receptor superfamily. Science 240:889, 1988
2. Strickland S, Mahdavi V: The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15:393, 1978
3. Koeffler HP: Induction of differentiation of human acute myelogenous leukemia cells: Therapeutic implications. Blood 62:709, 1983
4. Zelent A, Krust A, Petkovich M, Kastner P, Chambon P: Cloning of murine α and β retinoic acid receptor predominantly expressed in skin. Nature 339:714, 1989
5. Robertson A, Emami B, Mueller LM, Collins SJ: Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells. Mol Cell Biol 12:3743, 1992
6. Krust A, Green S, Argos P, Kumar V, Walter P, Bornet JM, Chambon P: The chicken oestrogen receptor sequence: Homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J 5:891, 1986
7. Leid M, Kastner P, Durand B, Krust A, Leroy P, Lyons R, Mendelsohn C, Nagpal S, Nakshatri H, Reibel C, Saunders M, Chambon P: Retinoic acid signal transduction pathways. Ann NY Acad Sci 684:19, 1993
8. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
9. Kessler J, Jones S, Levine N, Lynch P, Booth A, Meyskens FJ: Isotretinoin and cutaneous T-cell lymphoma (mycosis fingoides). Arch Dermatol 123:201, 1987
10. Lippman S, Meyskens FJ: Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med 107:499, 1987
11. Diverio D, LoCoco F, D'Adamo F, Biondi A, Fagioli M, Grignani F, Rambaldi A, Rossi V, Avvisati G, Petti MC, Testi AM, Liso V, Specchia G, Fioritoni G, Recchia A, Frassoni F, Ciolli S, Pelicci PG: Identification of DNA rearrangements at the RARα locus in all patients with acute promyelocytic leukemia (APL) and mapping of APL breakpoints within the RARα second intron. Blood 79:1, 1992
12. Chen SJ, Zhu YJ, Tong JH, Dong S, Huang W, Chen Y, Xiang WM, Zhang L, Song Li X, Qian GQ, Wang ZY, Chen Z, Larsen CJ, Berger R: Rearrangements in the second intron of the RARα gene are present in a large majority of patients with acute promyelocytic leukemia and are used as molecular marker for retinoic acid induced leukemic cell differentiation. Blood 78:2696, 1991
13. Kadam PR, Merchant AA, Advani SH: Cytogenetic findings in patients with acute promyelocytic leukemia and case of CML blast crisis with promyelocytic proliferation. Cancer Genet Cytogenet 50:109, 1990
14. Lai JL, Fenaux P, Zandecki M, Savary JB, Estienne MH, Jouet JP, Bauters F, Deminatti M: Promyelocytic blast crisis of Philadelphia-positive thrombocythemia with translocations (9; 22) and (15; 17). Cancer Genet Cytogenet 29:311, 1987
15. Takaku F, Ogawa S, Hirai H, Yamada K: Rearrangement of retinoic acid receptor α and PML in promyelocytic blast crisis of Ph chromosome positive chronic myelocytic leukemia with normal copies of chromosome 15. Blood 81:2469, 1993
16. Warrel RP Jr: Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications. Blood 82:1949, 1993
17. Pratt MAC, Kralova J, McBurney MW: A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol Cell Biol 10:6445, 1990
18. Robertson KA, Emami B, Collins SJ: Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80:1885, 1992
19. Li YP, Said F, Gallagher RE: Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-α. Blood 83:3298, 1994
20. Collins SJ, Tsai S: Dominant negative retinoic acid receptors arrest myeloid differentiation at multiple developmental stages. Proceedings of the International Conference on Differentiation Therapy 6:84a, 1995 (abstr)
21. Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP: Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332:1393, 1995
22. Fuqua SA, Chamnes GC, McGuire WL: Estrogen receptor mutations in breast cancer. J Cell Biochem 51:135, 1993
23. Karnik PS, Kulkarni S, Liu XP, Budd GT, Bukowski RM: Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res 54:349, 1994
24. Ausebel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K: Current Protocols in Molecular Biology, vol 1. New York, NY, Greene Publishing Associates and Wiley, 1993
25. Breitman TR, Selonick SE, Collins SJ: Induction of differentiation of the human promyelocytic cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936, 1980
26. Olsson IL, Breitman TR: Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3′:5′-monophosphate-inducing agents. Cancer Res 42:3924, 1982
27. Hemmi H, Breitman TR: Induction of functional differentiation of a human monocytic leukemia cell line (THP-1) by retinoic acid and cholera toxin. Jpn J Cancer Res 76:345, 1985
28. Douer D, Koeffler HP: Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro. Exp Cell Res 138:193, 1982
29. Koeffler HP, Heitjan D, Mertelsman R, Kolitz JE, Schulman P, Itri L, Gunter P, Besa E: Randomized study of 13-cis retinoic acid v placebo in myelodysplastic disorders. Blood 71:703, 1988
30. Besa EC, Abrahm JL, Bartholomew MJ, Hyzinski M, Nowell PC: Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol. Am J Med 89:739, 1990
31. Tsai S, Bartelmez S, Heyman R, Damm K, Evans R, Collins SJ: A mutated retinoic acid receptor-α exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev 6:2258, 1992
32. Tsai S, Collins SJ: A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 90:7153, 1993
33. Tsai S, Bartelmez S, Sitnicka E, Collins S: Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 8:2831, 1994
34. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM: The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16:325, 1993
35. Smooker-PM, Cotton-RG TI: The use of chemical reagents in the detection of DNA mutations. Mutat Res 288:65, 1993
36. Giguere V, Ong ES, Segui P, Evans RM: Identification of a receptor for the morphogen retinoic acid. Nature 330:624, 1987